Evidence map›Paper›PMID 35204753›Full record

ArticleBiomolecules2022

The Degradation of Hyaluronan in the Skin.

Petra Žádníková, Romana Šínová, Vojtěch Pavlík, Matěj Šimek, Barbora Šafránková, Martina Hermannová, Kristina Nešporová, Vladimír Velebný

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
8.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. 2-Methoxystypandrone fromAntioxidants (Basel, Switzerland) · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Petra ŽádníkováR&D Department, Contipro a.s., 561 02 Dolní Dobrouč, Czech Republic.
Romana ŠínováR&D Department, Contipro a.s., 561 02 Dolní Dobrouč, Czech Republic.ORCID 0000-0002-7282-9016
Vojtěch PavlíkR&D Department, Contipro a.s., 561 02 Dolní Dobrouč, Czech Republic.ORCID 0000-0002-6575-9726
Matěj ŠimekR&D Department, Contipro a.s., 561 02 Dolní Dobrouč, Czech Republic.ORCID 0000-0002-9570-315X
Barbora ŠafránkováR&D Department, Contipro a.s., 561 02 Dolní Dobrouč, Czech Republic.
Martina HermannováR&D Department, Contipro a.s., 561 02 Dolní Dobrouč, Czech Republic.
Kristina NešporováR&D Department, Contipro a.s., 561 02 Dolní Dobrouč, Czech Republic.ORCID 0000-0001-7864-7689
Vladimír VelebnýR&D Department, Contipro a.s., 561 02 Dolní Dobrouč, Czech Republic.
Contipro (Czechia) · CZCharles University · CZMasaryk University · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyaluronan (HA) comprises a fundamental component of the extracellular matrix and participates in a variety of biological processes. Half of the total amount of HA in the human body is present in the skin. HA exhibits a dynamic turnover; its half-life in the skin is less than one day. Nevertheless, the specific participants in the catabolism of HA in the skin have not yet been described in detail, despite the essential role of HA in cutaneous biology. A deeper knowledge of the processes involved will act to support the development of HA-based topical and implantable materials and enhance the understanding of the various related pathological cutaneous conditions. This study aimed to characterize the distribution and activity of hyaluronidases and the other proteins involved in the degradation of HA in healthy human full-thickness skin, the epidermis and the dermis. Hyaluronidase activity was detected for the first time in healthy human skin. The degradation of HA occurred in lysates at an acidic pH. HA gel zymography revealed a single band corresponding to approximately 50 kDa. This study provided the first comprehensive view of the distribution of canonic HA-degrading proteins (HYAL1 and HYAL2) in human skin employing IHF and IHC. Furthermore, contrary to previous assumptions TMEM2, a novel hyaluronidase, as well as CEMIP, a protein involved in HA degradation, were localized in the human epidermis, as well as in the dermis.

Indexed as

Hyaluronic AcidHyaluronoglucosaminidaseExtracellular MatrixHumansProteinsSkinHyaluronic AcidHyaluronoglucosaminidaseProteinsCEMIPdegradationhyaluronanhyaluronidaseskinTMEM2

Identifiers

PMID35204753
PMCPMC8961566
OpenAlexW4210481814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.